Merck Acquires Modifi And Preclinical Assets For GBM, Other Cancers

 
• By Alaric DeArment
  
Behind the Deal
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas